IPO Issue Details
Issue Price / Price Band₹79 per share (Fixed Price)
Face Value₹5 Per Share
Lot Size189 Shares per Lot
Total Issue Size2,08,86,200 shares (agg. up to ₹[.] Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital & OFS
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenFri, 20 Feb 2026
Subscription CloseTue, 24 Feb 2026
Anchor AllotmentThu, 19 Feb 2026
Basis of AllotmentWed, 25 Feb 2026
Initiation of RefundsWed, 25 Feb 2026
Credit of Shares to DematThu, 26 Feb 2026
Listing DateFri, 27 Feb 2026
UPI Mandate Deadline5:00 PM on 24 Feb 2026 (Day 3)
Application & Investment Details
Retail — Min (1 Lots)₹14,931 — 189 shares
Retail — Max (13 Lots)₹194,103 (13 Lots)
HNI — Min (67 Lots)₹10,00,377 — 12,663 shares
EPS (Pre-IPO)₹3.12
EPS (Post-IPO)₹3.44
P/E Ratio (Pre-IPO)25.36x
P/E Ratio (Post-IPO)22.99x
Pre-IPO Promoter Holding6,13,94,384 shares
Post-IPO Promoter Holding7,27,86,884 shares
Fresh Issue Shares1,13,92,500 shares (agg. up to ₹[.] Cr)
Offer for Sale Shares94,93,700 shares of ₹5 (agg. up to ₹[.] Cr)
About Gaudium IVF & Women Health Ltd
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.The company operates over thirty locations, which include seven hubs (centres) and twenty-eight spokes. The organization has entered into a strategic alliance with Infertility Experts, known as Spokes, to achieve the mutual objective of raising awareness regarding Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments.The company serves patients from various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.The company has centres in major cities: two in Delhi (Janakpuri, Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, covering key locations across India.The company offers specialized fertility services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction. Our treatments are designed for various infertility challenges for both genders. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis, as well as high-risk pregnancy management for women with complex fertility histories or health conditions.The facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques.Competitive StrengthPatient-Centric ApproachExpert teamUsing next-gen INTEGRA Ti labs for ICSI.Highly Technical USG Guided ServicesEstablished central hubs in prime urban locations, including Mumbai, Bangalore, Delhi NCR, and Patna.Asset Light Business Model
Objects of the Issue
Gaudium IVF & Women Health Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Funding capital expenditure towards establishment of New IVF Centers of the Company.
50.00
2
Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company.
20.00
3
General Corporate Purpose
Shareholding & Lock-in
Pre-IPO Promoter Holding
6,13,94,384 shares
Post-IPO Promoter Holding
7,27,86,884 shares
Lock-in Period (30%)Fri, Mar 27, 2026
Lock-in Period (50%)Tue, May 26, 2026